• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Arterial Stiffness and Vascular Aging: From Pathophysiology to Treatment, with a Look at the Future.

作者信息

Virdis Agostino

机构信息

Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, 56100, Pisa, Italy.

出版信息

High Blood Press Cardiovasc Prev. 2018 Jun;25(2):135-136. doi: 10.1007/s40292-018-0253-4. Epub 2018 Feb 22.

DOI:10.1007/s40292-018-0253-4
PMID:29470787
Abstract
摘要

相似文献

1
Arterial Stiffness and Vascular Aging: From Pathophysiology to Treatment, with a Look at the Future.
High Blood Press Cardiovasc Prev. 2018 Jun;25(2):135-136. doi: 10.1007/s40292-018-0253-4. Epub 2018 Feb 22.
2
The Role of Renin-Angiotensin-Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging.肾素-血管紧张素-醛固酮系统及其新组分在动脉僵硬度和血管衰老中的作用
High Blood Press Cardiovasc Prev. 2018 Jun;25(2):137-145. doi: 10.1007/s40292-018-0252-5. Epub 2018 Feb 23.
3
Comment on: IgA nephropathy with early kidney disease is associated with increased arterial stiffness and renin-angiotensin system activity.
J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):965-6. doi: 10.1177/1470320314529003. Epub 2014 Sep 10.
4
25-Hydroxyvitamin D status, arterial stiffness and the renin-angiotensin system in healthy humans.25-羟维生素 D 状态、动脉僵硬度与健康人体中的肾素-血管紧张素系统。
Clin Exp Hypertens. 2014;36(6):386-91. doi: 10.3109/10641963.2013.827705. Epub 2013 Oct 28.
5
Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.肾素-血管紧张素-醛固酮系统抑制剂和β受体阻滞剂对动脉僵硬度标志物的影响。
J Am Soc Hypertens. 2014 Feb;8(2):74-82. doi: 10.1016/j.jash.2013.09.001. Epub 2013 Oct 17.
6
IgA nephropathy with early kidney disease is associated with increased arterial stiffness and renin-angiotensin system activity.早期肾病的IgA肾病与动脉僵硬度增加和肾素-血管紧张素系统活性增加有关。
J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):521-8. doi: 10.1177/1470320313510586. Epub 2014 Jan 24.
7
Antihypertensive agents and arterial stiffness: relevance to reducing cardiovascular risk in the chronic kidney disease patient.抗高血压药物与动脉僵硬度：与降低慢性肾脏病患者心血管风险的相关性
Curr Opin Nephrol Hypertens. 2007 Sep;16(5):409-15. doi: 10.1097/MNH.0b013e3282063b86.
8
Arterial stiffness in atherosclerotic renovascular hypertension.动脉粥样硬化性肾血管性高血压中的动脉僵硬度
J Hypertens. 2014 Nov;32(11):2238-45; discussion 2245. doi: 10.1097/HJH.0000000000000324.
9
Arterial stiffness and pulse pressure in CKD and ESRD.CKD 和 ESRD 中的动脉僵硬度和脉压。
Kidney Int. 2012 Aug;82(4):388-400. doi: 10.1038/ki.2012.131.
10
Vital roles of age and metabolic syndrome-associated risk factors in sex-specific arterial stiffness across nearly lifelong ages: Possible implication of menopause and andropause.年龄和代谢综合征相关风险因素在几乎整个生命周期中对性别特异性动脉僵硬度的重要作用：绝经和男性更年期的可能影响。
Atherosclerosis. 2017 Mar;258:26-33. doi: 10.1016/j.atherosclerosis.2017.01.023. Epub 2017 Jan 20.

引用本文的文献

1
Multimodality comparison of aorta morphology in patients with aortopathy: 4D flow CMR, CTA, mDIXON.主动脉病变患者主动脉形态的多模态比较：四维血流心脏磁共振成像、CT血管造影、多 Dixon 成像
BMC Med Imaging. 2025 Jun 3;25(1):201. doi: 10.1186/s12880-025-01734-w.
2
Efficacy of γ-linolenic acid, Vitis vinifera extract, and acetyl-L-carnitine combination therapy for improving arterial stiffness in Korean adults: Real-world evidence.γ-亚麻酸、葡萄(Vitis vinifera)提取物和乙酰左旋肉碱联合治疗改善韩国成年人动脉僵硬度的疗效：真实世界证据。
J Clin Hypertens (Greenwich). 2023 Sep;25(9):880-888. doi: 10.1111/jch.14708. Epub 2023 Aug 22.
3

本文引用的文献

1
The Role of Renin-Angiotensin-Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging.肾素-血管紧张素-醛固酮系统及其新组分在动脉僵硬度和血管衰老中的作用
High Blood Press Cardiovasc Prev. 2018 Jun;25(2):137-145. doi: 10.1007/s40292-018-0252-5. Epub 2018 Feb 23.
2
Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease.血管平滑肌细胞与动脉僵硬度：在发生发展、衰老及疾病中的相关性。
Physiol Rev. 2017 Oct 1;97(4):1555-1617. doi: 10.1152/physrev.00003.2017.
3
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.
A fluid-structure interaction model accounting arterial vessels as a key part of the blood-flow engine for the analysis of cardiovascular diseases.
一种将动脉血管视为血流引擎关键部分的流固耦合模型，用于心血管疾病分析。
Front Bioeng Biotechnol. 2022 Aug 19;10:981187. doi: 10.3389/fbioe.2022.981187. eCollection 2022.
4
Vascular Ageing and Aerobic Exercise.血管衰老与有氧运动。
Int J Environ Res Public Health. 2021 Oct 12;18(20):10666. doi: 10.3390/ijerph182010666.
5
Inflammaging as a link between autoimmunity and cardiovascular disease: the case of rheumatoid arthritis.炎症性衰老作为自身免疫和心血管疾病之间的联系：以类风湿关节炎为例。
RMD Open. 2021 Jan;7(1). doi: 10.1136/rmdopen-2020-001470.
6
Brazilian Position Statement on Resistant Hypertension - 2020.《巴西2020年难治性高血压立场声明》
Arq Bras Cardiol. 2020 May-Jun;114(3):576-596. doi: 10.36660/abc.20200198.
7
Multivariate Analysis of Influence of Vitamin Intake on Vascular Function Parameters by Sex in the General Spanish Population: EVA Study.多变量分析维生素摄入对普通西班牙人群血管功能参数的性别影响：EVA 研究。
Nutrients. 2020 Feb 28;12(3):643. doi: 10.3390/nu12030643.
血管生物标志物在一级和二级预防中的作用。欧洲心脏病学会外周循环工作组的立场文件：得到动脉结构和生理学研究协会（ARTERY 协会）的认可。
Atherosclerosis. 2015 Aug;241(2):507-32. doi: 10.1016/j.atherosclerosis.2015.05.007. Epub 2015 May 16.
4
Vascular biology of ageing-Implications in hypertension.衰老的血管生物学——对高血压的影响
J Mol Cell Cardiol. 2015 Jun;83:112-21. doi: 10.1016/j.yjmcc.2015.04.011. Epub 2015 Apr 17.
5
Association of aging, arterial stiffness, and cardiovascular disease: a review.衰老、动脉僵硬度与心血管疾病的关联：综述
Cardiol Rev. 2014 Sep-Oct;22(5):223-32. doi: 10.1097/CRD.0000000000000009.
6
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理指南：欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理特别工作组
J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
7
Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts.使用 SCORE、Framingham 和 ESH/ESC 风险图表的脉搏波速度、尿白蛋白肌酐比和左心室质量指数的阈值。
J Hypertens. 2012 Oct;30(10):1928-36. doi: 10.1097/HJH.0b013e328356c579.
8
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity.使用颈股脉搏波速度在日常实践中测量主动脉僵硬度的专家共识文件。
J Hypertens. 2012 Mar;30(3):445-8. doi: 10.1097/HJH.0b013e32834fa8b0.
9
Hypertension in the elderly: an evidence-based review.老年人高血压：基于证据的综述。
Curr Pharm Des. 2011;17(28):3020-31. doi: 10.2174/138161211798157711.
10
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.动脉僵硬度预测心血管事件和全因死亡率：系统评价和荟萃分析。
J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27. doi: 10.1016/j.jacc.2009.10.061.